{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:03:46Z","timestamp":1789718626639,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05384-0","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:30:47Z","timestamp":1789716647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addressing evidence gaps in haemodialysis care: a critical review of clinical trials, technological innovations, and implementation priorities"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-1552","authenticated-orcid":false,"given":"Sharon","family":"Huish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8085-9936","authenticated-orcid":false,"given":"Rebecca","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-9622","authenticated-orcid":false,"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-6833","authenticated-orcid":false,"given":"Andrew","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-7081","authenticated-orcid":false,"given":"Charles J.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-5368","authenticated-orcid":false,"given":"Mark","family":"Lambie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Morlidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-5156","authenticated-orcid":false,"given":"Rona","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-3478","authenticated-orcid":false,"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7759-7816","authenticated-orcid":false,"given":"Fokko P.","family":"Wieringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-7592","authenticated-orcid":false,"given":"James O.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"11","key":"5384_CR1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021;143(11):1157\u201372.","journal-title":"Circulation"},{"issue":"3","key":"5384_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41581-021-00518-z","volume":"18","author":"K Kalantar-Zadeh","year":"2022","unstructured":"Kalantar-Zadeh K, Lockwood MB, Rhee CM, Tantisattamo E, Andreoli S, Balducci A, et al. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat Rev Nephrol. 2022;18(3):185\u201398.","journal-title":"Nat Rev Nephrol"},{"key":"5384_CR3","volume-title":"UK Renal Registry 26th Annual Report","author":"UK Renal Registry","year":"2024","unstructured":"UK Renal Registry. UK Renal Registry 26th Annual Report. Bristol: UK Kidney Association; 2024."},{"issue":"1","key":"5384_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13063-020-4139-0","volume":"21","author":"J He","year":"2020","unstructured":"He J, Morales DR, Guthrie B. Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic review. Trials. 2020;21(1):228.","journal-title":"Trials"},{"issue":"5","key":"5384_CR5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048\u201350.","journal-title":"Kidney Int"},{"key":"5384_CR6","unstructured":"Kidney Research UK. Kidney disease: a UK public health emergency. London; 2023."},{"key":"5384_CR7","volume-title":"Fit for the future: 10 Year Health Plan for England","author":"Department of Health and Social Care","year":"2025","unstructured":"Department of Health and Social Care. Fit for the future: 10 Year Health Plan for England. London: Department of Health and Social Care; 2025. Available online at:. https:\/\/www.gov.uk\/government\/publications\/10-year-health-plan-for-england-fit-for-the-future."},{"key":"5384_CR8","unstructured":"British Heart Foundation. Annual report and accounts 2024\u201325. London: British Heart Foundation; 2025. Available from: https:\/\/www.bhf.org.uk\/-\/media\/files\/what-we-do\/annual-reports\/annual-report-and-accounts-2025.pdf.\u00a0"},{"key":"5384_CR9","unstructured":"Cancer Research UK. Annual report and accounts 2024\/25. London: Cancer Research UK; 2025. Available from: https:\/\/www.cancerresearchuk.org\/about-us\/our-organisation\/annual-reports. 2025. Accessed 5 August 2026."},{"key":"5384_CR10","unstructured":"Kidney Research UK. Annual report 2023\/24. Peterborough: Kidney Research UK; 2024. Available from: https:\/\/www.kidneyresearchuk.org\/wp-content\/uploads\/2024\/10\/1510-KRUK-Annual-Report-23-24-PDFUA.pdf."},{"issue":"1","key":"5384_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13063-018-2489-7","volume":"19","author":"F Chinnery","year":"2018","unstructured":"Chinnery F, Bashevoy G, Blatch-Jones A, Douet L, Puddicombe S, Raftery J. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease. Trials. 2018;19(1):87.","journal-title":"Trials"},{"key":"5384_CR12","doi-asserted-by":"crossref","unstructured":"Burton JO, Hull KL, Quann N, Waheed G, Gray LJ. Extended in-centre nocturnal versus conventional daytime dialysis: the NightLife Trial [conference abstract]. J Am Soc Nephrol. 2025;36(10S).","DOI":"10.1681\/ASN.2025k059ds7e"},{"issue":"1","key":"5384_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s13063-023-07565-w","volume":"24","author":"KL Hull","year":"2023","unstructured":"Hull KL, Bramham K, Brookes CL, Cluley V, Conefrey C, Cooper NJ, et al. The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial. Trials. 2023;24(1):522.","journal-title":"Trials"},{"issue":"2","key":"5384_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2513032","volume":"394","author":"CE Lok","year":"2026","unstructured":"Lok CE, Farkouh M, Hemmelgarn BR, Moist LM, Polkinghorne KR, Tomlinson G, et al. Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. N Engl J Med. 2026;394(2):128\u201337.","journal-title":"N Engl J Med"},{"issue":"6","key":"5384_CR15","doi-asserted-by":"publisher","first-page":"sfag168","DOI":"10.1093\/ckj\/sfag168","volume":"19","author":"CJ Ferro","year":"2026","unstructured":"Ferro CJ, Thomas MR, Khattak S, Chanouzas D, Townend JN. Fish oil supplements in patients with chronic kidney disease. Clin Kidney J. 2026;19(6):sfag168.","journal-title":"Clin Kidney J"},{"key":"5384_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2458-14-204","volume":"14","author":"YF Zhang","year":"2014","unstructured":"Zhang YF, Gao HF, Hou AJ, Zhou YH. Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials. BMC Public Health. 2014;14:204.","journal-title":"BMC Public Health"},{"issue":"11","key":"5384_CR17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119\u201327.","journal-title":"JAMA"},{"key":"5384_CR18","unstructured":"National Institute for Health and Care Research (NIHR). Reporting platform for studies on the RDN portfolio. NIHR. Available from: https:\/\/www.nihr.ac.uk\/support-and-services\/support-for-delivering-research\/reporting-platform-studies-rdn-portfolio. (Accessed 22 May 2026)."},{"key":"5384_CR19","unstructured":"National Institute for Health and Care Research (NIHR). Be Part of Research: search for studies. Available from: https:\/\/bepartofresearch.nihr.ac.uk\/ (accessed 5 August 2026)."},{"issue":"9","key":"5384_CR20","doi-asserted-by":"publisher","first-page":"sfae259","DOI":"10.1093\/ckj\/sfae259","volume":"17","author":"FP Wieringa","year":"2024","unstructured":"Wieringa FP, Bolhuis D, Sondergaard H, Ash SR, Cummins C, Gerritsen KGF, et al. Transportable, portable, wearable and (partially) implantable haemodialysis systems: comparison of technologies and readiness levels. Clin Kidney J. 2024;17(9):sfae259.","journal-title":"Clin Kidney J"},{"issue":"6","key":"5384_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.ajkd.2024.10.015","volume":"85","author":"FP Wieringa","year":"2025","unstructured":"Wieringa FP, Suran S, Sondergaard H, Ash S, Cummins C, Chaudhuri AR, et al. The Future of Technology-Based Kidney Replacement Therapies: An Update on Portable, Wearable, and Implantable Artificial Kidneys. Am J Kidney Dis. 2025;85(6):787\u201396.","journal-title":"Am J Kidney Dis"},{"key":"5384_CR22","unstructured":"ISO\/TC 150\/SC 2\/WG 5. Renal replacement, detoxification and apheresis working-group update [unpublished committee material presented at the UK Haemodialysis Research Nexus, 11 May 2026; meeting held in Caparica, Portugal, 23\u201325 September 2025]."},{"issue":"1","key":"5384_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-025-04053-3","volume":"32","author":"GT Ribas","year":"2026","unstructured":"Ribas GT, Cunha AF, Avila JP, Giarraputo A, Morena L, Lima K, et al. Immune profiling in a living human recipient of a gene-edited pig kidney. Nat Med. 2026;32(1):270\u201380.","journal-title":"Nat Med"},{"issue":"2","key":"5384_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ndt\/gfad150","volume":"39","author":"VRL Gullapudi","year":"2024","unstructured":"Gullapudi VRL, Cox EF, Buchanan CE, Canaud B, White K, Taal MW, et al. Randomized trial comparing standard versus thermocontrolled haemodialysis using intradialytic cardiac, brain and renal magnetic resonance imaging. Nephrol Dial Transpl. 2024;39(2):233\u201341.","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"5384_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2215\/CJN.01030117","volume":"12","author":"KCW Leung","year":"2017","unstructured":"Leung KCW, Quinn RR, Ravani P, Duff H, MacRae JM. Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis. Clin J Am Soc Nephrol. 2017;12(11):1831\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5384_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s40620-023-01844-0","volume":"37","author":"E Mambelli","year":"2024","unstructured":"Mambelli E, Grandi F, Santoro A. Comparison of blood volume biofeedback hemodialysis and conventional hemodialysis on cardiovascular stability and blood pressure control in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials. J Nephrol. 2024;37(4):897\u2013909.","journal-title":"J Nephrol"},{"key":"5384_CR27","unstructured":"National Institute for Health and Care Research (NIHR). Inclusive research funding application guidance. Available from: https:\/\/www.nihr.ac.uk\/about-us\/who-we-are\/research-inclusion\/funding-application-guidance (Accessed 05\/05\/26). 2024."},{"key":"5384_CR28","unstructured":"National Institute for Health and Care Research (NIHR). Sex and gender in research policy. Available from: https:\/\/www.nihr.ac.uk\/about-us\/who-we-are\/policies-and-guidelines\/sex-and-gender-research (accessed 05\/05\/26). 2025."},{"issue":"3","key":"5384_CR29","doi-asserted-by":"publisher","first-page":"e058368","DOI":"10.1136\/bmjopen-2021-058368","volume":"12","author":"P Kaushal","year":"2022","unstructured":"Kaushal P, Adenwalla SF, Lightfoot CJ, March DS, Gray LJ, Burton JO. Evaluation of the design, conduct and reporting of randomised controlled trials in the haemodialysis population: a scoping review and interview study. BMJ Open. 2022;12(3):e058368.","journal-title":"BMJ Open"},{"key":"5384_CR30","unstructured":"James Lind Alliance. JLA guidebook. National Institute for Health and Care Research; Available from: https:\/\/www.jla.nihr.ac.uk\/jla-guidebook\/"},{"issue":"5","key":"5384_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa1810742","volume":"380","author":"IC Macdougall","year":"2019","unstructured":"Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, et al. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. N Engl J Med. 2019;380(5):447\u201358.","journal-title":"N Engl J Med"},{"issue":"1","key":"5384_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12882-025-04115-1","volume":"26","author":"S Bhandari","year":"2025","unstructured":"Bhandari S, Spencer S, Oliveira B, Mikhail A, Brooks O, Bryant G, et al. UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease. BMC Nephrol. 2025;26(1):193.","journal-title":"BMC Nephrol"},{"issue":"3","key":"5384_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/sdi.13250","volume":"38","author":"S Spencer","year":"2025","unstructured":"Spencer S, Hunter S, Bhandari S. On the Cusp-A Questionnaire-Based Assessment of Implementing PIVOTAL Into UK Practice. Semin Dial. 2025;38(3):214\u201320.","journal-title":"Semin Dial"},{"key":"5384_CR34","unstructured":"Wellcome Trust, Academy of Medical Sciences, Medical Research Council, Department of Health. Medical research: what\u2019s it worth? London; 2018. Available from: https:\/\/acmedsci.ac.uk\/file-download\/54792223."},{"issue":"1","key":"5384_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12882-025-04374-y","volume":"26","author":"E Aitken","year":"2025","unstructured":"Aitken E, Anijeet H, Ashby D, Barrow W, Calder F, Dowds B, et al. UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis. BMC Nephrol. 2025;26(1):461.","journal-title":"BMC Nephrol"},{"issue":"4\u20135","key":"5384_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/17449871241235636","volume":"29","author":"S Alabacak","year":"2024","unstructured":"Alabacak S, Arslan S. The relationship between self-care behaviours regarding arteriovenous fistula and the fear of fistula failure in individuals receiving haemodialysis treatment. J Res Nurs. 2024;29(4\u20135):388\u201398.","journal-title":"J Res Nurs"},{"key":"5384_CR37","doi-asserted-by":"publisher","first-page":"100050","DOI":"10.1016\/j.jvsvi.2023.100050","volume":"2","author":"FR Udwadia","year":"2024","unstructured":"Udwadia FR, Cohen D, Gu N, Mordhorst A, Skala T, Hsiang YN, et al. Practical and ethical challenges of maintaining vascular access in chronic kidney disease: A qualitative interview study. JVS-Vascular Insights. 2024;2:100050.","journal-title":"JVS-Vascular Insights"},{"key":"5384_CR38","unstructured":"The Dialysis Outcomes and Practice Patterns Study. DOPPS programme information. Available from: https:\/\/www.dopps.org\/ (Accessed 5 August 2026)."},{"issue":"1","key":"5384_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.ajkd.2016.05.022","volume":"69","author":"A Tong","year":"2017","unstructured":"Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, et al. Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis. 2017;69(1):97\u2013107.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05384-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05384-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05384-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:30:54Z","timestamp":1789716654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05384-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5384"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05384-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article reports an academic meeting and did not involve a research intervention or systematic collection of identifiable participant data. Sessions were not audio- or video-recorded for this report. The authors used contemporaneous slides and notes.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable. No identifiable individual information is published.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"SH is Chair of the Kidney Research UK Clinical Study Group for CKD associated Mineral Bone Disorders. SB is Vice President of the Royal College of Physicians of Edinburgh and former Trustee of Kidney Research UK. CF is Vice-Chair of the Cardiovascular Medicine Working Group and Chair of the Strong Kidneys Task Force of the European Renal Association. ML is Co-Chair of both the UK Kidney Association Home Therapies Special Interest Group and Kidney Research UK Dialysis Research Innovation Network. CM is a Trustee and Former President of the UK Kidney Association. RS is the Chief Investigator of the NIHR funded PHOSPHATE Trial and Deputy Chair of the Kidney Research UK Renal Trials Network. DW is the NIHR National Specialty Lead for Renal Disorders. FPW received financial support from the European Innovation Council (KIDNEW, HORIZON-EIC-2022 Pathfinder program, grant agreement no. 101099092), as well as from the Dutch national growth fund (NXTGEN HighTech Biomed04 \u201cArtificial Organs\u201d project) and is a technology consultant to NextKidney. JOB is funded (Senior Investigator Award) by the National Institute for Health and Care Research (NIHR). The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care. He is Clinical Vice-President and a Trustee of the UK Kidney Association. RB and SM declare no relevant competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"548"}}